1. Home
  2. OFLX vs ACRS Comparison

OFLX vs ACRS Comparison

Compare OFLX & ACRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omega Flex Inc.

OFLX

Omega Flex Inc.

N/A

Current Price

$29.01

Market Cap

333.0M

Sector

Industrials

ML Signal

N/A

Logo Aclaris Therapeutics Inc.

ACRS

Aclaris Therapeutics Inc.

N/A

Current Price

$3.67

Market Cap

311.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OFLX
ACRS
Founded
1975
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
333.0M
311.0M
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
OFLX
ACRS
Price
$29.01
$3.67
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$9.75
AVG Volume (30 Days)
31.8K
1.2M
Earning Date
06-12-2026
05-27-2026
Dividend Yield
4.55%
N/A
EPS Growth
N/A
69.01
EPS
1.13
N/A
Revenue
$101,681,000.00
$1,683,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$26.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.58
$1.05
52 Week High
$41.74
$4.89

Technical Indicators

Market Signals
Indicator
OFLX
ACRS
Relative Strength Index (RSI) 29.81 60.83
Support Level $26.32 $2.76
Resistance Level $29.54 $3.78
Average True Range (ATR) 1.91 0.22
MACD -1.07 0.03
Stochastic Oscillator 22.16 91.41

Price Performance

Historical Comparison
OFLX
ACRS

About OFLX Omega Flex Inc.

Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.

Share on Social Networks: